These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 32201198
21. Intermittent inotropic therapy with levosimendan vs. milrinone in advanced heart failure patients. Milwidsky A, Frydman S, Laufer-Perl M, Sadeh B, Sapir O, Granot Y, Hochstadt A, Korotetski L, Ketchker L, Topilsky Y, Banai S, Havakuk O. ESC Heart Fail; 2022 Apr; 9(2):1487-1491. PubMed ID: 35083882 [Abstract] [Full Text] [Related]
22. Use of levosimendan, a new inodilator, for postoperative myocardial stunning in a premature neonate. Lechner E, Moosbauer W, Pinter M, Mair R, Tulzer G. Pediatr Crit Care Med; 2007 Jan; 8(1):61-3. PubMed ID: 17149153 [Abstract] [Full Text] [Related]
24. Effects of Combined Milrinone and Levosimendan Treatment on Systolic and Diastolic Function During Postischemic Myocardial Dysfunction in a Porcine Model. Axelsson B, Häggmark S, Svenmarker S, Johansson G, Gupta A, Tydén H, Wouters P, Haney M. J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):495-503. PubMed ID: 26837238 [Abstract] [Full Text] [Related]
26. The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan. Haikala H, Kaheinen P, Levijoki J, Lindén IB. Cardiovasc Res; 1997 Jun; 34(3):536-46. PubMed ID: 9231037 [Abstract] [Full Text] [Related]
27. Levosimendan in cardiac surgery: current best available evidence. Raja SG, Rayen BS. Ann Thorac Surg; 2006 Apr; 81(4):1536-46. PubMed ID: 16564321 [Abstract] [Full Text] [Related]
31. Levosimendan is superior to milrinone and dobutamine in selectively increasing microvascular gastric mucosal oxygenation in dogs. Schwarte LA, Picker O, Bornstein SR, Fournell A, Scheeren TW. Crit Care Med; 2005 Jan; 33(1):135-42; discussion 246-7. PubMed ID: 15644660 [Abstract] [Full Text] [Related]
33. Prophylactic use of levosimendan in pediatric patients undergoing cardiac surgery: a prospective randomized controlled trial. Wang A, Cui C, Fan Y, Zi J, Zhang J, Wang G, Wang F, Wang J, Tan Q. Crit Care; 2019 Dec 30; 23(1):428. PubMed ID: 31888711 [Abstract] [Full Text] [Related]
36. Effectiveness of prophylactic levosimendan in patients with impaired left ventricular function undergoing coronary artery bypass grafting: a randomized pilot study. Anastasiadis K, Antonitsis P, Vranis K, Kleontas A, Asteriou C, Grosomanidis V, Tossios P, Argiriadou H. Interact Cardiovasc Thorac Surg; 2016 Nov 30; 23(5):740-747. PubMed ID: 27378790 [Abstract] [Full Text] [Related]
37. A quantitative comparison of functional and anti-ischaemic effects of the phosphodiesterase-inhibitors, amrinone, milrinone and levosimendan in rabbit isolated hearts. Rump AF, Acar D, Klaus W. Br J Pharmacol; 1994 Jul 30; 112(3):757-62. PubMed ID: 7921599 [Abstract] [Full Text] [Related]
38. [Individualized use of levosimendan in cardiac surgery]. Woehrle T, Mehringer L, Juchem G, Dashkevich A, Weis M, Schünemann M, Kilger E. Anaesthesist; 2021 Mar 30; 70(3):204-212. PubMed ID: 33001236 [Abstract] [Full Text] [Related]
39. Proarrhythmic changes in human cardiomyocytes during hypothermia by milrinone and isoprenaline, but not levosimendan: an experimental in vitro study. Selli AL, Ghasemi M, Watters T, Burton F, Smith G, Dietrichs ES. Scand J Trauma Resusc Emerg Med; 2023 Oct 25; 31(1):61. PubMed ID: 37880801 [Abstract] [Full Text] [Related]